Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Sanofi-Aventis joins YouTube revolution

February 18, 2009
Sales and Marketing Sanofi-Aventis, diabetes

Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …

News

Lilly launches diabetes patient education programme

September 12, 2008
Medical Communications, Sales and Marketing diabetes, patients

Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …

News

Delayed Galvus cleared for 2008 European launch

December 19, 2007
Sales and Marketing EU, diabetes

A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …

News

Avandia suffering less in Europe

December 10, 2007
Sales and Marketing Avandia, diabetes

New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …

News

Dwindling sales mean job cuts at GSK

October 25, 2007
Sales and Marketing Avandia, diabetes

GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …

News

Pfizer abandons Exubera

October 19, 2007
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …

News

FDA allows Avandia to stay but damage already done

August 3, 2007
Sales and Marketing diabetes

An FDA advisory committee has recommended that GlaxoSmithKline's diabetes treatment Avandia should remain available on the US market, albeit with …

News

Avandia scare casts doubt over its future for Alzheimer’s

June 13, 2007
Sales and Marketing Avandia, diabetes, safety

 New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …

News

Januvia launched in UK

April 25, 2007
Sales and Marketing Januvia, diabetes

Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …

News

Diabetes UK report criticises cutbacks in NHS

March 23, 2007
diabetes

In a new report, Diabetes UK has criticised cutbacks in NHS diabetes treatment, suggesting that service reductions are putting patients' …

News

New diabetes drug launched in UK

March 14, 2007
Sales and Marketing Byetta, diabetes

A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …

News

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

News

Byetta receives EU approval for Type II diabetes

November 28, 2006
Sales and Marketing diabetes

Lilly and Amylin's new diabetes treatment, Byetta, has won EU approval.It is the first in a new class of anti-diabetic …

News

Surprise delay for Novartis’ Galvus

November 15, 2006
Sales and Marketing Galvus, diabetes

The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …

News

New diabetes drug Byetta set for European approval

September 22, 2006
Sales and Marketing Byetta, diabetes

Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026